Marija Simic-Geroldinger

Ordensklinikum Linz Elisabethinen
Linz, AT 
Ordensklinikum Linz Elisabethinen
Linz, AT 

Overview

Marija Simic-Geroldinger practices practicing medicine in Linz, Austria.

Her clinical expertise encompasses Leukocyte Adhesion Deficiency Type 1, Systemic Sclerosis (SSc), Scleroderma, and Darier Disease.

She is actively involved in clinical research, co-authoring 16 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Ordensklinikum Linz Elisabethinen
Linz, Austria

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 1 Less Clinical Trial

16 Total Publications

Immune cells composition in the skin and subcutaneous adipose tissue of patients with systemic sclerosis.
Immune cells composition in the skin and subcutaneous adipose tissue of patients with systemic sclerosis.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: January 31, 2025

Frequently Asked Questions about Marija Simic-Geroldinger

Is Marija Simic-Geroldinger a top-rated expert for Leukocyte Adhesion Deficiency Type 1?

MediFind is an objective health platform that identifies experts based on real-world data. Marija Simic-Geroldinger is classified as an Experienced expert for Leukocyte Adhesion Deficiency Type 1, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Marija Simic-Geroldinger participate in research or clinical trials?

Yes. Marija Simic-Geroldinger has published 16 articles and abstracts on conditions like Leukocyte Adhesion Deficiency Type 1. You can view a list of Marija Simic-Geroldinger's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Simic-Geroldinger's expertise for a condition
ConditionClose
        View All 11 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile